An experienced life science entrepreneur based in San Francisco, CA, USA. Tero-Pekka Alastalo (MD, PhD) has 12+ years’ experience in life science startups and +10 years of clinical and translational research experience. His previous roles include heading North American operations at CardioSignal and co-founding Blueprint Genetics, which was acquired in 2020.